A detailed history of Claris Financial LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Claris Financial LLC holds 1,663 shares of ABT stock, worth $205,580. This represents 0.19% of its overall portfolio holdings.

Number of Shares
1,663
Previous 2,473 32.75%
Holding current value
$205,580
Previous $328,000 31.1%
% of portfolio
0.19%
Previous 0.23%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 26, 2025

SELL
$123.95 - $138.08 $100,399 - $111,844
-810 Reduced 32.75%
1,663 $226,000
Q4 2024

Jun 16, 2025

BUY
$111.93 - $119.39 $276,802 - $295,251
2,473 New
2,473 $280 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $216B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Claris Financial LLC Portfolio

Follow Claris Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Claris Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Claris Financial LLC with notifications on news.